Basic Research
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2006; 12(5): 716-722
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.716
Figure 1
Figure 1 No increase of COX and iNOS expression levels by IL-1β. (A) The cultured cat ESMCs were treated with IL-1β for 18 h at each dose scale. The COX-1 and COX-2 expression levels were not altered by IL-1β at concentrations up to 50 ng/mL. (B) The IL-1β (25 ng/mL) treatment also failed to elevate the level after 24 h. (C) iNOS expression was unaffected by IL-1β.